Cargando…
MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1(+) tumor immunity in mice
MF59 is an oil-in-water emulsion adjuvant approved for influenza vaccines for human use in Europe. Due to its Th2 inducing properties, MF59 is seldom tested for cancer vaccines. In this study, MF59 formulated with a C-type CpG oligodeoxynucleotide (YW002) was tested for its Th1 adjuvant activity to...
Autores principales: | Yang, Ming, Yan, Youyou, Fang, Mingli, Wan, Min, Wu, Xiuli, Zhang, Xiaoling, Zhao, Tiesuo, Wei, Hongfei, Song, Dandan, Wang, Liying, Yu, Yongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106219/ https://www.ncbi.nlm.nih.gov/pubmed/22595192 http://dx.doi.org/10.1016/j.intimp.2012.05.003 |
Ejemplares similares
-
MF59 Promoted the Combination of CpG ODN1826 and MUC1-MBP Vaccine-Induced Antitumor Activity Involved in the Enhancement of DC Maturation by Prolonging the Local Retention Time of Antigen and Down-Regulating of IL-6/STAT3
por: Jie, Jing, et al.
Publicado: (2022) -
Promoter CpG methylation in cancer cells contributes to the regulation of MUC4
por: Yamada, N, et al.
Publicado: (2009) -
Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012) -
The effect of CpG-ODN on antigen presenting cells of the foal
por: Flaminio, M Julia BF, et al.
Publicado: (2007) -
Effect of CpG ODN on monocytic myeloid derived suppressor cells
por: Shirota, Hidekazu, et al.
Publicado: (2012)